Steven Cohen Ac Immune Sa Transaction History

Point72 Asset Management, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$4.83 - $7.56 $1.1 Million - $1.72 Million	-228,000 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$6.2 - $8.34 $921,320 - $1.24 Million	-148,600 Reduced 39.46%	228,000 $1.53 Million
Q2 2021 Aug 16, 2021	BUY	$6.04 - $8.37 $2.27 Million - $3.15 Million	376,600 New	376,600 $2.99 Million

28.2M

150K

12.4K

Ticker ACIU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,413,504
Market Cap $296M
Description
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.